FILTER

Refine your search with the following facets to narrow down your results.

3 Current news of Inovio Biomedical

Inovio Biomedical's DNA Vaccine Delivery Technology Moves Ahead in Clinical Trial for Hepatitis C

Inovio initiates 5th DNA vaccine clinical study: hepatitis C

01-Nov-2007 - Inovio Biomedical Corporation announced that its partner, Tripep AB of Sweden, has begun enrolling patients for its Phase I/II clinical study of a novel DNA vaccine designed to treat chronically infected hepatitis C virus (HCV) patients. The trial will test Tripep's proprietary DNA vaccine, ...

clinical trials electroporation hepatitis C +2

Inovio Biomedical Redirects Strategic Emphasis toward DNA Vaccines and DNA Delivery

Company expanding R&D to advance its DNA delivery technology and develop proprietary DNA vaccines for cancer and chronic infectious diseases

11-Oct-2007 - Inovio Biomedical Corporation announced it is focusing its research and development efforts on its electroporation-mediated DNA delivery technology and DNA vaccines with the objective of further building potential downstream value to existing and prospective partners. Overall, management has ...

clinical trials electroporation flow +5

Inovio Biomedical's DNA Delivery Technology Significantly Enhances Potency of Gene-Based Prostate Cancer Vaccine

Key Milestone for First-in-Man DNA Vaccine Clinical Trial Using Inovio's Electroporation DNA Delivery Technology

25-May-2007 - Inovio Biomedical Corp., focused on the development of DNA-based vaccines for cancers and infectious diseases and a novel alternative to surgery to treat localized cancers, announced that interim data from a clinical study of an experimental DNA-based prostate cancer vaccine demonstrated that ...

clinical trials electroporation immunotherapies +5